Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| CA2095 | CA38150 | U.S. | 2003 | HIV1 | B | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | AZT | 44 |
| 2 | AZT+ DDI | 21 |
| 3 | AZT+ DDC+ SQV | 22 |
| 4 | AZT+ DDC+ RTV | 25 |
| 5 | 3TC+ AZT+ IDV | 31 |
| 6 | 3TC+ AZT+ NVP | 1 |
| 7 | 3TC+AZT+RTV+SQV | 58 |
| 8 | D4T+DDI+EFV+Unknown | 34 |
| 9 | APV+D4T+DDC+EFV+SQV | 6 |
| 10 | APV+D4T+DDI+EFV+NFV | 65 |
| 11 | APV+D4T+DDI+EFV+LPV | 79 |
| 12 | Unknown | 58 |
Protease Sequence
| PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
| M46I, I50V, I54V, V82A, L90M | L33F, F53L | L10I, I13V, K20R, E35D, M36I, N37S, R41K, R57RK, D60E, I62V, L63P, A71V |
| >CA38150| codons 1-99 PQITLWQRPIVTVKIGGQLREALLDTGADDTVFEDISLPGKWKPKIIGGVGGLVKVKQYE QVPIEICGHKVIGTVLVGPTPANIIGRNLMTQIGCTLNF |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| M41L, K65R, Q151M, L210W | A62V, V75I, F116Y, T215D | G190S | K43Q, S68R, W88S, K101Q, V118I, K122E, R172K, I202V, F214L, E248D, K281R, A288S, I293V, E297K |
| >CA38151| codons 1-300 PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTELEQEGKISKIGPENPYNTPV FVIKRKDRTKWRKLIDFRELNKRTQDFSEVQLGIPHPAGLQKKKSVTVLDVGDAYYSIPL DEDFRKYTAFTIPSINNETPGIRYQYNVLPMGWKGSPAIFQSSMTKILEPFKKQNPDIVI YQYMDDLYVSSDLEIGQHRTKVEELRQHLWRWGLDTPDKKHQKEPPFLWMGYELHPDKWT VQPIVLPDKDSWTVNDIQKLVGKLNWASQIYAGIKVKQLCRLLRGTKSLTEVVPLTKEAE |
References
| Author | Title | Citation |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |